0001209191-15-042027.txt : 20150512 0001209191-15-042027.hdr.sgml : 20150512 20150512214720 ACCESSION NUMBER: 0001209191-15-042027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150508 FILED AS OF DATE: 20150512 DATE AS OF CHANGE: 20150512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC CENTRAL INDEX KEY: 0001178879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200422823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 662-2000 MAIL ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Valenzano Ken CENTRAL INDEX KEY: 0001492123 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33497 FILM NUMBER: 15856306 MAIL ADDRESS: STREET 1: 6 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-08 0 0001178879 AMICUS THERAPEUTICS INC FOLD 0001492123 Valenzano Ken 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 0 1 0 0 SVP, Pharmacology & Biology Common stock 2015-05-08 4 M 0 25000 A 25000 D Common stock 2015-05-08 4 F 0 9313 10.80 D 15687 D Common stock 2015-05-11 4 S 0 5000 10.8399 D 10687 D Common stock 2015-05-11 4 S 0 8000 10.8513 D 2687 D Restricted stock units 2015-05-08 4 M 0 25000 0.00 D Common Stock 25000 25000 D Restricted stock units convert into common stock on a one-for-one basis. The sale of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2014. This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.7262 to $10.95. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The sale of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014. This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.73 to $10.98. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. On April 10, 2014, the reporting person was granted 50,000 restricted stock units, vesting in equal installments of 25,000 restricted stock units on May 10, 2015 and 25,000 restricted stock units on December 3, 2015. /s/ Ken Valenzano 2015-05-12